Wednesday, February 10, 2016

Bucks congressman's plan to shield little firms from big audits

Is Fitzpatrick's "Fomenting Innovation" act actually a "Mediocrities" protection bill?

Bucks congressman's plan to shield little firms from big audits


It's ten years since the Enron scandal prompted the Sarbanes-Oxley act that requires stepped-up audits of big U.S. companies. President Obama has encouraged Congress to chip away SarBox paperwork requirements for "emerging" companies he hopes will hire more Americans.

So in 2010. the Dodd-Frank law exempted companies with public shares worht less than $75 million. Last Spring the so-called JOBS Act gave companies. with shares worth under $700M and sales under $1B, a five-year SarbOx audit delay.

Now US Rep. Mike Fitzpatrick, R-Bucks, is pushing a permanent SarbOx audit exemption for companies with shares under $250 million or sales under $100 million. He calls his bill (HB 6161) the "Fostering Innovation Act."

How would this help Bucks County? At a hearing in Congress Thursday, Jeffrey S. Hatfield, chief executive of Fort Washington-based Vitae Pharmaceuticals, plans to testify on behalf of the Biotechnology Industry Organization, an industry lobby, in support of Fitzpatrick's bill.

Vitae, which employs 55, has spent ten years working on therapies for kidney disease and other chronic sickness. Hatfield says he'd like to raise money from public investors by doing an initial public stock offering -- but SarbOx audits would cost Vitae a million dollars a year, he estimates, and that's too much for such a small firm.

Hatfield says previous trims to SarbOx have encouraged more biotech firms to file for IPOs. He says Fitzpatrick's exemptions would encourage still more.

But Columbia University Prof. John Coffey, a corporate-governance expert who will also testify, ridicules Fitzpatrick's bill as the "Mature Mediocrities Act." 

Previous SarbOx cuts resulted in Britain's 135-year-old, money-losing Manchester United football team filing a US IPO and winning exemption as an "emerging company," making the US an object of "mockery," Coffey notes.

He says Fitzpatrick's exemption would give the companies most in need of oversight and disclosure an "open-ended' exemption from audit scrutiny. Instead of continuing to offer investors the world's best protection, the U.S. is moving desperately toward wide-open markets, where investors had best beware.

Fitzpatrick's willing to take that risk, if it will help companies raise more money and maybe hire more people. 

We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog

PhillyDeals posts interviews, drafts and updates that Joseph N. DiStefano writes alongside his Sunday and Monday columns and ongoing articles about Philadelphia-area business.

DiStefano studied economics, history and a little engineering at Penn. He taught writing and research at St. Joe’s. He has written for the Inquirer since 1989, except when he left a few times to work at Bloomberg and elsewhere. He wrote the book Comcasted, and raised six kids with his wife, who is a saint.

Reach Joseph N. at, 215.854.5194, @PhillyJoeD. Read his blog posts at and his Inquirer columns at Bloomberg posts his items at NH BLG_PHILLYDEAL.

Reach Joseph N. at or 215 854 5194.

Joseph N. DiStefano
Also on
letter icon Newsletter